No Relief: Rising MS Drug Prices

Welcome to the NeurologyLive Mind Moments podcast.

 

In this episode, Daniel M. Hartung, PharmD, MPH, associate professor of pharmacy at Oregon State University College of Pharmacy, discusses findings of a report he and colleagues compiled on rising spending in the US Medicaid program on disease-modifying therapies for multiple sclerosis, and the unique nature of their prices in the United States. 

 

For more on MS and other neurology topics, visit NeurologyLive.com. Thanks for listening.